HomeRXRX • NASDAQ
add
Recursion Pharmaceuticals Inc
Previous close
$4.85
Day range
$4.80 - $5.00
Year range
$3.79 - $12.36
Market cap
2.10B USD
Avg Volume
17.41M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 19.22M | 33.34% |
Operating expense | 46.65M | 46.56% |
Net income | -171.90M | -76.23% |
Net profit margin | -894.23 | -32.17% |
Earnings per share | -0.41 | -2.50% |
EBITDA | -152.38M | -66.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 525.11M | 10.70% |
Total assets | 1.30B | 67.86% |
Total liabilities | 383.21M | 100.20% |
Total equity | 919.15M | — |
Shares outstanding | 434.66M | — |
Price to book | 2.29 | — |
Return on assets | -33.79% | — |
Return on capital | -43.32% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -171.90M | -76.23% |
Cash from operations | -76.42M | 7.06% |
Cash from investing | -5.81M | -38.88% |
Cash from financing | 97.66M | -62.88% |
Net change in cash | 24.69M | -86.02% |
Free cash flow | -22.46M | 45.53% |
About
Founded
2013
Headquarters
Website
Employees
800
